| HDVAX | VFWPX | HDVAX / VFWPX | |
| Total Expense Ratio | 0.97 | 0.03 | 3,233% |
| Annual Report Gross Expense Ratio | 0.97 | 0.03 | 3,233% |
| Fund Existence | 18 years | 15 years | - |
| Gain YTD | 26.881 | 29.164 | 92% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 708M | 76.1B | 1% |
| Annual Yield % from dividends | 1.55 | 2.69 | 57% |
| Returns for 1 year | 25.68 | 28.18 | 91% |
| Returns for 3 years | 51.53 | 49.71 | 104% |
| Returns for 5 years | 37.26 | 32.98 | 113% |
| Returns for 10 years | 91.19 | 78.85 | 116% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| EMM | 33.75 | 0.06 | +0.16% |
| Global X Emerging Markets ex-China ETF | |||
| UAPR | 32.81 | 0.03 | +0.09% |
| Innovator U.S. Equity Ultra BffrETF™-Apr | |||
| DUHP | 38.52 | 0.01 | +0.03% |
| Dimensional US High Profitability ETF | |||
| MYCK | 25.03 | N/A | N/A |
| SPDR SSGA My2031 Corporate Bond ETF | |||
| HNDL | 22.14 | -0.01 | -0.05% |
| Strategy Shares Nasdaq 7 Handl™ ETF | |||